ValeurQ4, 24Q1, 25Q2, 25Q3, 25Total du passif39.55 M39.32 M39.81 M39.06 MTotal des capitaux propres-865 K-5.65 M-9.21 M-13 MTotal du passif et des capitaux propres38.68 M33.67 M30.6 M26.06 MDette totale27.29 M———Dette nette5.38 M———
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.